查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386605

医疗仿生市场报告：2030 年趋势、预测与竞争分析

Medical Biomimetics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

医学仿生学的趋势与预测

预计到 2030 年，全球医学仿生市场将达到约 566 亿美元，2024 年至 2030 年年复合成长率为 7.0%。该市场的主要驱动力是政府增加对生物识别研究的投资以及医疗保健领域机械工程和奈米技术的整合和进步。全球医疗仿生市场的未来前景广阔，医院和专科中心市场蕴藏商机。

医学仿生市场洞察

Lucintel 预测，由于牙齿问题发生率的增加和牙科仿生产品的高采用率，牙科预计在预测期内将经历最高的增长。

在这个市场中，由于手术病例的增加和全球慢性病盛行率的上升，创伤治疗可能仍然是最大的部分。

由于需要使用牙科仿生产品的牙科问题的增加以及政府对仿生产品研究的资助增加，北美在预测期内可能仍然是最大的市场。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 哪些细分市场最有前景且成长潜力最大？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球医疗仿生市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球医学仿生市场趋势（2018-2023）与预测（2024-2030）
  • 按疾病类型分類的全球医学仿生市场
    • 心血管
    • 整形外科
    • 眼科
    • 牙科
    • 其他的
  • 全球医疗仿生市场应用
    • 创伤治疗
    • 人体组织工程
    • 药物输送
    • 其他的
  • 按最终用途分類的全球医疗仿生市场
    • 医院
    • 专业中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球医疗仿生市场区域分布
  • 北美医疗仿生市场
  • 欧洲医学仿生市场
  • 亚太医疗仿生市场
  • 其他区域医疗仿生市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按疾病类型分類的全球医学仿生市场成长机会
    • 全球医疗仿生学市场成长机会（按应用）
    • 全球医疗仿生市场最终用途的成长机会
    • 按地区分類的全球医疗仿生市场成长机会
  • 全球医学仿生市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球医学仿生市场的产能
    • 全球医学仿生市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • AVINENT
  • BioHorizons
  • Blatchford
  • CorNeat Vision
  • Curasan
  • Keystone Dental
  • Osteopore International
  • Otsuka Medical Devices
  • Swedish Biomimetics
  • Zimmer Biomet
简介目录

Medical Biomimetics Trends and Forecast

The future of the global medical biomimetics market looks promising with opportunities in the hospital and specialty centre markets. The global medical biomimetics market is expected to reach an estimated $56.6 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are increasing government investment in biometrics research, coupled with the integration, and advancement of mechanical engineering and nanotechnology in the healthcare sector.

A more than 150-page report is developed to help in your business decisions.

Medical Biomimetics by Segment

The study includes a forecast for the global medical biomimetics by disease type, application, end use, and region.

Medical Biomimetics Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Others

Medical Biomimetics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Others

Medical Biomimetics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Centres
  • Others

Medical Biomimetics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Medical Biomimetics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies medical biomimetics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the medical biomimetics companies profiled in this report include-

  • Avinent
  • Biohorizons
  • Blatchford
  • Corneat Vision
  • Curasan
  • Keystone Dental
  • Osteopore International
  • Otsuka Medical Devices
  • Swedish Biomimetics
  • Zimmer Biomet

Medical Biomimetics Market Insights

Lucintel forecasts that dental is expected to witness highest growth over the forecast period due to increasing incidence of dental problems and the high adoption of dental biomimetics product.

Within this market, wound healing will remain the largest segment due to increasing number of surgical cases and rising prevalence of chronic diseases across the globe.

North America will remain the largest segment over the forecast period due to increasing dental issues necessitating the use of dental biomimetics products and heightened government funding for biomimetics product research.

Features of the Global Medical Biomimetics Market

Market Size Estimates: Medical biomimetics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Medical biomimetics market size by disease type, application, end use, and region in terms of value ($B).

Regional Analysis: Medical biomimetics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease types, applications, end uses, and regions for the medical biomimetics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the medical biomimetics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the medical biomimetics market size?

Answer: The global medical biomimetics market is expected to reach an estimated $56.6 billion by 2030.

Q.2 What is the growth forecast for medical biomimetics market?

Answer: The global medical biomimetics market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the medical biomimetics market?

Answer: The major drivers for this market are increasing government investment in biometrics research, coupled with the integration and advancement of mechanical engineering and nanotechnology in the healthcare sector.

Q4. What are the major segments for medical biomimetics market?

Answer: The future of the medical biomimetics market looks promising with opportunities in the hospital and specialty centre markets.

Q5. Who are the key medical biomimetics market companies?

Answer: Some of the key medical biomimetics companies are as follows:

  • Avinent
  • Biohorizons
  • Blatchford
  • Corneat Vision
  • Curasan
  • Keystone Dental
  • Osteopore International
  • Otsuka Medical Devices
  • Swedish Biomimetics
  • Zimmer Biomet

Q6. Which medical biomimetics market segment will be the largest in future?

Answer: Lucintel forecasts that dental is expected to witness highest growth over the forecast period due to increasing incidence of dental problems and the high adoption of dental biomimetics product.

Q7. In medical biomimetics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to increasing dental issues necessitating the use of dental biomimetics products and heightened government funding for biomimetics product research.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the medical biomimetics market by disease type (cardiovascular, orthopedic, ophthalmology, dental, and others), application (wound healing, tissue engineering, drug delivery, and others), end use (hospitals, specialty centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Medical Biomimetics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Medical Biomimetics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Medical Biomimetics Market by Disease Type
    • 3.3.1: Cardiovascular
    • 3.3.2: Orthopedic
    • 3.3.3: Ophthalmology
    • 3.3.4: Dental
    • 3.3.5: Others
  • 3.4: Global Medical Biomimetics Market by Application
    • 3.4.1: Wound Healing
    • 3.4.2: Tissue Engineering
    • 3.4.3: Drug Delivery
    • 3.4.4: Others
  • 3.5: Global Medical Biomimetics Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Centres
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Medical Biomimetics Market by Region
  • 4.2: North American Medical Biomimetics Market
    • 4.2.2: North American Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others
  • 4.3: European Medical Biomimetics Market
    • 4.3.1: European Medical Biomimetics Market by Disease Type: Cardiovascular, Orthopedic, Ophthalmology, Dental, and Others
    • 4.3.2: European Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others
  • 4.4: APAC Medical Biomimetics Market
    • 4.4.1: APAC Medical Biomimetics Market by Disease Type: Cardiovascular, Orthopedic, Ophthalmology, Dental, and Others
    • 4.4.2: APAC Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others
  • 4.5: ROW Medical Biomimetics Market
    • 4.5.1: ROW Medical Biomimetics Market by Disease Type: Cardiovascular, Orthopedic, Ophthalmology, Dental, and Others
    • 4.5.2: ROW Medical Biomimetics Market by End Use: Hospitals, Specialty Centres, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Medical Biomimetics Market by Disease Type
    • 6.1.2: Growth Opportunities for the Global Medical Biomimetics Market by Application
    • 6.1.3: Growth Opportunities for the Global Medical Biomimetics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Medical Biomimetics Market by Region
  • 6.2: Emerging Trends in the Global Medical Biomimetics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Medical Biomimetics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Medical Biomimetics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: AVINENT
  • 7.2: BioHorizons
  • 7.3: Blatchford
  • 7.4: CorNeat Vision
  • 7.5: Curasan
  • 7.6: Keystone Dental
  • 7.7: Osteopore International
  • 7.8: Otsuka Medical Devices
  • 7.9: Swedish Biomimetics
  • 7.10: Zimmer Biomet